AI in Action E274: Mark DePristo, Founder & CEO at BigHat Biosciences
AI in Action, Podcast | October 25 2021 | JP Valentine
Welcome to episode 274 of the AI in Action podcast, the show where we break down the hype and explore the impact that Data Science, Machine Learning and Artificial Intelligence are making on our everyday lives.
Powered by Alldus International, our goal is to share with you the insights of technologists and data science enthusiasts to showcase the excellent work that is being done within AI in the United States and Europe.
Today’s guest is Mark DePristo, Founder & CEO at BigHat Biosciences in San Francisco, CA. Founded in 2019, BigHat’s mission is to improve human health by making it far easier to design advanced, next-generation antibody therapeutics. Mark brings a wealth of experience to the company having previously founded and led the Genomics team in Google Brain and holds a PhD in Biochemistry from the University of Cambridge.
BigHat Biosciences’ AI-enabled experimental platform integrates a high-speed characterization or “wet” lab with machine learning technologies to speed the antibody engineering process. When applied, these design capabilities have the potential to drive the development of new generations of safer and more effective treatments for patients suffering from today’s most challenging diseases.
In the episode, Mark will chat about:
His motivation for launching BigHat Biosciences
The success they’ve had in the past two years
The problems they are solving for customers
What excites him for the future
Exciting opportunities within the team
To find out more about Mark and all the great work happening at BigHat Biosciences check out the website www.bighatbio.com or follow them on Linkedin and Twitter @BigHatBio. You can also follow Mark on Twitter @MarkDePristo or connect with him on Linkedin.
What did you think of Mark’s podcast? Where do you see the future of AI and Data Science in the healthcare industry heading in the next few years? We would love to hear your thoughts on this episode, so please leave a comment below.
If you would like to hear more from The Alldus Podcast then please subscribe and don’t forget to like and share with your friends on social media.
Subscribe to The Alldus Podcast:
Welcome to episode 274 of the AI in Action podcast, the show where we break down the hype and explore the impact that Data Science, Machine Learning and Artificial Intelligence are making on our everyday lives.
Powered by Alldus International, our goal is to share with you the insights of technologists and data science enthusiasts to showcase the excellent work that is being done within AI in the United States and Europe.
Today’s guest is Mark DePristo, Founder & CEO at BigHat Biosciences in San Francisco, CA. Founded in 2019, BigHat’s mission is to improve human health by making it far easier to design advanced, next-generation antibody therapeutics. Mark brings a wealth of experience to the company having previously founded and led the Genomics team in Google Brain and holds a PhD in Biochemistry from the University of Cambridge.
BigHat Biosciences’ AI-enabled experimental platform integrates a high-speed characterization or “wet” lab with machine learning technologies to speed the antibody engineering process. When applied, these design capabilities have the potential to drive the development of new generations of safer and more effective treatments for patients suffering from today’s most challenging diseases.
In the episode, Mark will chat about:
His motivation for launching BigHat Biosciences
The success they’ve had in the past two years
The problems they are solving for customers
What excites him for the future
Exciting opportunities within the team
To find out more about Mark and all the great work happening at BigHat Biosciences check out the website www.bighatbio.com or follow them on Linkedin and Twitter @BigHatBio. You can also follow Mark on Twitter @MarkDePristo or connect with him on Linkedin.
What did you think of Mark’s podcast? Where do you see the future of AI and Data Science in the healthcare industry heading in the next few years? We would love to hear your thoughts on this episode, so please leave a comment below.
If you would like to hear more from The Alldus Podcast then please subscribe and don’t forget to like and share with your friends on social media.
Subscribe to The Alldus Podcast:
share
related podcasts
ServiceNow Series E199: Thomas Cohrs, CEO at Servistio
Welcome to episode 199 in our ServiceNow series of the Alldus podcast, the show where we highlight the brightest talent and technical leadership within the ServiceNow ecosystem. Powered by Alldus International, our goal is to share with you the insights of leaders in the field to showcase the excellent work that is being done within…
ServiceNow Series E198: David McInnes, ServiceNow Engagement Manager & Andrew Ortiz, ServiceNow Practice Director at AdvizeX
Welcome to episode 198 in our ServiceNow series of the Alldus podcast, the show where we highlight the brightest talent and technical leadership within the ServiceNow ecosystem. Powered by Alldus International, our goal is to share with you the insights of leaders in the field to showcase the excellent work that is being done within…
Women in ServiceNow Series E08: Lise Fremo Furre, Partner at KPMG Norway
Welcome to the episode eight in our Women in ServiceNow series Alldus podcast, a brand new series dedicated to showcasing the incredible women leading the way in the ServiceNow ecosystem. Powered by Alldus International, host Ailsa Cassie brings you inspiring conversations with trailblazing women who are driving innovation, breaking barriers, and shaping the future of…